The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.
Biological engineering
With AI, researchers predict the location of virtually any protein within a human cell
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
Read MoreA quarter century after its founding, the McGovern Institute reflects on its discoveries in the areas of neuroscience, neurotechnology, artificial intelligence, brain-body connections, and therapeutics.
Read MoreFragFold, developed by MIT Biology researchers, is a computational method with potential for impact on biological research and therapeutic applications.
Read MoreMIT spinout maps the body’s metabolites to uncover the hidden drivers of disease
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Read MoreWhen MIT’s interdisciplinary NEET program is a perfect fit
Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.
Read MoreA causal theory for studying the cause-and-effect relationships of genes
By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.
Read More

You must be logged in to post a comment.